US: 800.298.5699
Int'l: +1.240.747.3093
Matching geography
Reports matching your search in:
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!

Personalized Medicine Market Research Reports & Industry Analysis

RSS Feeds

Personalized Medicine Industry Research & Market Reports

Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019
9/24/2014 | published by: MarketsandMarkets
... global cell isolation market is expected to reach $5.1 billion by 2019 from $2.5 billion in 2014, growing at a CAGR of 15.8% from 2014 to 2019. The global cell isolation market is categorized on ...  |  read more...
USD 5,650
Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management
2/1/2015 | published by: CHI Insight Pharma Reports
... A major drawback of the tissue-based approach centers on the need for invasive surgical procedures in sample collection, which in a great many instances preclude following the progression or regression of disease during therapy. In ...  |  read more...
USD 2,495
Next-generation Healthcare—Global Advanced Medical Technologies 2014
12/15/2014 | published by: Frost & Sullivan
... toward business models built around value and quality of service. Companies with solutions around specific procedures or treatments could see attrition as cost pressures and reimbursements continue to undercut future market opportunity for expansion, while ...  |  read more...
USD 4,950
Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (US)
5/1/2015 | published by: FirstWord
... and Challenges at the Physician Level (US) is based on survey results from 50 US oncologists (33 medical oncologists and 17 haematologist-oncologists) and offers insights on what oncologists believe are the critical issues, challenges and ...  |  read more...
USD 6,900
Plunkett's Biotech & Genetics Industry Trends & Statistics 2015: A Summary Version of Plunkett's Biotech & Genetics Industry Almanac 2015
10/25/2014 | published by: Plunkett Research, Ltd.
... 60 Statistical Tables Provided: 16 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Biotech & Genetics Industry Almanac 2015, including forecasts and market estimates, technologies analysis and vital statistical tables. You will ...  |  read more...
USD 199.99
Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)
4/1/2009 | published by: Kalorama Information
... personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this ...  |  read more...
USD 995
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
... the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara ...  |  read more...
USD 3,500
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
... selection, therapy monitoring and early detection of cancer recurrence. The market for cancer testing are comprehensively covered in Kalorama Information's Worldwide Market for Cancer Diagnostics, 5th. Edition. This report, authored by Kalorama Diagnostic Analyst Shara ...  |  read more...
USD 2,995
Biotech Funding Deals and Partnerships: Analysis of Recent Venture Capital and Corporate Capital Funding and Other Transactions
5/20/2014 | published by: Kalorama Information
... notable spike. In the last few years, this has resulted in a complex series of deals and transactions, ranging from complete buyouts, to licensing transactions, to a variety of collaborative arrangements. In addition to this ...  |  read more...
USD 3,500
SNP Genotyping and Analysis Markets and the Future of SNPs in Personalized Medicine
2/1/2010 | published by: Kalorama Information
... exhibited by a living organism. For this reason, SNP analysis represents one of many possible pathways to personalzied medicine. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and ...  |  read more...
USD 1,995
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine)
6/1/2008 | published by: Kalorama Information
... the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as ...  |  read more...
USD 2,995
Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends and Forecasts (2013 – 2
9/25/2013 | published by: MarketsandMarkets
... and measurable characteristic, which identifies the severity and/or occurrence of a specific disease. It has major applications in the discovery and development of novel therapeutic drugs. The global biomarkers market shows a high growth potential ...  |  read more...
USD 5,650
Global Molecular Cytogenetics Market 2014-2018
6/13/2014 | published by: TechNavio - Infiniti Research Ltd.
... Inc. , Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Illumina Inc., PerkinElmer Inc., Applied Spectral Imaging Ltd, Biological Industries Ltd, Bio-Rad Laboratories Inc., Cytognomix Inc., CytoTest Inc., Illumina Inc., Kreatech Inc. , Leica Biosystems Ltd, ...  |  read more...
USD 2,500
Conference Documentation: Oncology imaging for drug development
3/12/2014 | published by: SMI Publishing, Ltd
... consider the current landscape of personalised imaging within the field of oncology. SMi's 10th annual event on oncology imaging will provide delegates with a comprehensive insight into current and future legislation and its impact on ...  |  read more...
USD 788.78
Deals in Oncology Personalized Medicine Industry – Worldwide Analysis
5/27/2014 | published by: Renub Research
... by the world’s leading healthcare companies in oncology sector. All the deals have been tracked year wise. All the deals have been covered under different chapters in below mentioned topics. Collaboration Deals (Chapter No. 2.1) ...  |  read more...
USD 900
Companion Diagnostics – Streamlining Drug Development and Advancing Personalized Medicine
4/1/2013 | published by: CBR Pharma Insights, LLC
... to gain ground. Companion diagnostics can be used in screening, monitoring, diagnosing and treating patients and can allow for stratification of patients to maximize efficacy and minimize risk Companion diagnostics can allow for a specific ...  |  read more...
USD 3,900
Personalized Medicine Partnering Terms and Agreements
4/1/2014 | published by: Current Partnering
... report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why ...  |  read more...
USD 3,295
Personalizing Cancer Drugs Trends
1/1/2014 | published by: Global Industry Analysts
... the report presents an overview on the mechanism instrumental for causing some forms of breast cancer may also be responsible for promoting a subset of melanoma or brain cancer. The improved knowledge of cancer genetics ...  |  read more...
USD 1,450
Cancer Peptides: From First-in-Class to Best-in-Class?
1/7/2013 | published by: BioSeeker Group AB
... Which targets, tumor types and companies are setting the path? What is first-in-class in the cancer peptide pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and ...  |  read more...
USD 3,675
Biomarkers Market Discovery Technologies (Proteomics, Genomics, Imaging, Bioinformatics), Applications (Drug Discovery, Personalized Medicine, Molecular Diagnostics) & Indications (Cancer, Cardiovascular & Neural) Global Trends & Forecasts (2011 - 2020)
2/2/2012 | published by: MarketsandMarkets
... based on different parameters such as on the basis of their application, their characteristics and on their usage in decision making in early drug development. With drug development facing challenges from ever increasing cost of ...  |  read more...
USD 5,650
Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018
9/30/2013 | published by: MarketsandMarkets
... significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global cancer/tumor profiling market is valued at $14.99 billion in 2013 ...  |  read more...
USD 5,650
Breast Cancer Therapies Markets
11/1/2012 | published by: TriMark Publications
... such barriers to entry as a stringent regulatory environment and the incursion of cost containment within oncology. Breast Cancer Therapies Markets provides comprehensive information on major and minor shapers of the breast cancer drug treatment ...  |  read more...
USD 2,500
The Impact of Health and Wellness on Products and Services
6/13/2012 | published by: Frost & Sullivan
... and openness and transparency - have been discussed. These four have been shortlisted among the others because greener products would have higher acceptance and increased demand, digitalization would be the key to reduce growing healthcare ...  |  read more...
USD 4,950
Future of Personalized Genomics-Technical Insights
3/31/2014 | published by: Frost & Sullivan
... a while host of indications. Embracing genetic best tests, will help world economies by reducing the millions of dollars spent in present diagnostic approaches. Preventative healthcare will also become a more concrete lifestyle choice due ...  |  read more...
USD 4,950
The 2013-2018 Outlook for Genetic Testing Services in Greater China
5/19/2013 | published by: Icon Group International, Inc.
... Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or ...  |  read more...
USD 495